The DeWorm3 Project, Department of Life Sciences, Natural History Museum, London, United Kingdom.
Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, United Kingdom.
PLoS Negl Trop Dis. 2019 Mar 21;13(3):e0007196. doi: 10.1371/journal.pntd.0007196. eCollection 2019 Mar.
Prevalence is a common epidemiological measure for assessing soil-transmitted helminth burden and forms the basis for much public-health decision-making. Standard diagnostic techniques are based on egg detection in stool samples through microscopy and these techniques are known to have poor sensitivity for individuals with low infection intensity, leading to poor sensitivity in low prevalence populations. PCR diagnostic techniques offer very high sensitivities even at low prevalence, but at a greater cost for each diagnostic test in terms of equipment needed and technician time and training. Pooling of samples can allow prevalence to be estimated while minimizing the number of tests performed. We develop a model of the relative cost of pooling to estimate prevalence, compared to the direct approach of testing all samples individually. Analysis shows how expected relative cost depends on both the underlying prevalence in the population and the size of the pools constructed. A critical prevalence level (approx. 31%) above which pooling is never cost effective, independent of pool size. When no prevalence information is available, there is no basis on which to choose between pooling and testing all samples individually. We recast our model of relative cost in a Bayesian framework in order to investigate how prior information about prevalence in a given population can be used to inform the decision to choose either pooling or full testing. Results suggest that if prevalence is below 10%, a relatively small exploratory prevalence survey (10-15 samples) can be sufficient to give a high degree of certainty that pooling may be relatively cost effective.
患病率是评估土壤传播性蠕虫负担的常用流行病学指标,也是许多公共卫生决策的基础。标准诊断技术基于粪便样本中通过显微镜检测卵,这些技术对于感染强度低的个体的敏感性较差,导致低患病率人群的敏感性较差。聚合酶链反应(PCR)诊断技术即使在低患病率时也具有非常高的敏感性,但每个诊断测试所需的设备、技术人员的时间和培训成本都更高。样本汇集可以在最小化测试数量的同时估计患病率。我们开发了一种患病率估计的相对成本模型,与直接测试所有样本的方法进行比较。分析表明,预期的相对成本取决于人群中的基础患病率和构建的样本池的大小。存在一个临界患病率水平(约 31%),高于该水平,汇集永远不会具有成本效益,与样本池的大小无关。当没有患病率信息时,就没有依据在汇集和单独测试所有样本之间做出选择。为了研究在给定人群中关于患病率的先验信息如何用于告知选择汇集或全部测试的决策,我们在贝叶斯框架中重新构建了相对成本模型。结果表明,如果患病率低于 10%,则相对较小的探索性患病率调查(10-15 个样本)就足以高度确定汇集可能具有相对成本效益。